HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 30.49
-0.78 (-2.49%)
At close: Sep 11, 2026
HitGen Employees
HitGen had 546 employees as of December 31, 2025. The number of employees increased by 63 or 13.04% compared to the previous year.
Employees
546
Change (1Y)
63
Growth (1Y)
13.04%
Revenue / Employee
1.18M CNY
Profits / Employee
256.66K CNY
Market Cap
12.21B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 546 | 63 | 13.04% |
| Dec 31, 2024 | 483 | 31 | 6.86% |
| Dec 31, 2023 | 452 | -56 | -11.02% |
| Dec 31, 2022 | 508 | 37 | 7.86% |
| Dec 31, 2021 | 471 | 13 | 2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Tibet Cheezheng Tibetan Medicine | 3,203 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Shanghai Medicilon | 2,504 |
| Jinyu Bio-technology | 1,881 |
| GemPharmatech | 1,692 |
| Jiangxi Fushine Pharmaceutical | 1,663 |
| Mabwell (Shanghai) Bioscience | 1,325 |